Global Vulvovaginal Candidiasis Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet. The Vulvovaginal Candidiasis market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Vulvovaginal Candidiasis market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Vulvovaginal Candidiasis Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Vulvovaginal Candidiasis market are: Kingyork Group Sanofi Pfizer Bayer J & J Teva Effik Cisen Pharmaceutical Perrigo Bristol-Myers Squibb Most important types of Vulvovaginal Candidiasis products covered in this report are: Miconazole Clotrimazole Fluconazole Econazole Other Most widely used downstream fields of Vulvovaginal Candidiasis market covered in this report are: Hospital & Clinic Pharmacy Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.